Sign in
CompletedPhase 3

Does high-dose vitamin B3 supplementation prevent major adverse kidney events during septic shock? A multicenter randomized controlled study

Key facts

Who runs it
Centre Hospitalier Universitaire Amiens Picardie
Where
France12 sites in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 3
People taking part
310 people enrolled
Started
13 Sept 2024
Ended
11 Sept 2025
Type of study
Interventional
Record updated
2 June 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Adult patients with septic shock defined as sepsis with persisting hypotension requiring vasopressors to maintain MAP ≥65 mm Hg and having a serum lactate level >2 mmol/L (18 mg/dL) despite adequate volume resuscitation

Who cannot take part

  • Immediate indication to start renal replacement therapy at the time of randomization
  • Resuscitated cardiac arrest
  • Known severe chronic kidney disease (clearance <30 ml /min) in the last 3 months preceding the setic shock or kidney transplant recipient
  • Presence of inclusion criteria for more than 24 hours
  • Hyperkalemia≥ 6.5 mmol /l, metabolic acidosis with pH <7.15 not controlled by medical treatment, diuretic resistant acute pulmonary edema or accumulation of a toxic requiring dialysis
  • Formal indication of Nicotinamide supplementation according to the attending physician (eg pellagra, undernutrition, severe alcoholism)
  • Moribund patient (estimated survival less than 24 hours)
  • Patient admitted to intensive care for more than 5 days

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

to show the superiority of Nicotinamide supplementation compared to the placebo group, in patients with septic shock admitted to intensive care

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Does high-dose vitamin B3 supplementation prevent major adverse kidney events during septic shock? A multicenter randomized controlled study.
Record updated
2 June 2025